- This event has passed.
French Tech Boston presents: The Road to Successful Fundraising for International Startups
May 22, 2019 @ 6:00 pm - 8:00 pm
FACCNE is pleased to power the inaugural event of French Tech Boston since its official labelling on April 3rd. Join us at Sanofi Genzyme’s headquarters in Kendall Square to hear from our panel of startup CEOs and investors, who will share their experiences and advice for successful fundraising strategies. The panel will include:
— Adrien Nussenbaum, whose company Mirakl, the leading global marketplace solutions provider, raised $70 million led by Bain Capital Ventures this February, with participation from existing investors 83North, Felix Capital and Elaia Partners, bringing total capital raised to $100 million.
— Patrick Tricoli, whose company, Nanobiotix, a pioneer and leader in nanomedicine, has developed a revolutionary approach to the treatment of cancer that has obtained market approval in Europe and accelerated its clinical development in the USA. The public company, on Euronext since 2012, has raised a total of $82.2M in funding over 5 rounds and plans to conduct registered public offering in the United States.
— Holly Maloney is a managing partner of General Catalyst where she invests in later-stage high growth software driven companies, such as The Predictive Index, Allego and Teamworks. Holly and her team have the insights to grow a successful business into one that defines or disrupts a category. She began her investing career at Guidepost Growth Equity (FKA: North Bridge Growth Equity) where she invested in companies such as WP Engine and Dyn. Her philosophy as an investor is to bring entrepreneurs exceptional value through a trusted partnership — helping to scale their companies to the next level while further innovating, building unique cultures, and delivering an excellent customer experience.
THIS EVENT IS NOW SOLD OUT – It is intended for entrepreneurs, executives and professionals seeking into investment or best practices for startups. FACCNE reserves the right at its discreet discretion to limit attendance.